Cargando…
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197092/ https://www.ncbi.nlm.nih.gov/pubmed/35701541 http://dx.doi.org/10.1038/s41422-022-00681-3 |
| _version_ | 1784727327802916864 |
|---|---|
| author | Liu, Xiaoqiang Li, Yuhua Wang, Zhongfang Cao, Shouchun Huang, Weijin Yuan, Lin Huang, Yi-Jiao Zheng, Yan Chen, Jingjing Ying, Bo Xiang, Zuoyun Shi, Jin Zhao, Jincun Huang, Zhen Qin, Cheng-Feng |
| author_facet | Liu, Xiaoqiang Li, Yuhua Wang, Zhongfang Cao, Shouchun Huang, Weijin Yuan, Lin Huang, Yi-Jiao Zheng, Yan Chen, Jingjing Ying, Bo Xiang, Zuoyun Shi, Jin Zhao, Jincun Huang, Zhen Qin, Cheng-Feng |
| author_sort | Liu, Xiaoqiang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9197092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91970922022-06-17 Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults Liu, Xiaoqiang Li, Yuhua Wang, Zhongfang Cao, Shouchun Huang, Weijin Yuan, Lin Huang, Yi-Jiao Zheng, Yan Chen, Jingjing Ying, Bo Xiang, Zuoyun Shi, Jin Zhao, Jincun Huang, Zhen Qin, Cheng-Feng Cell Res Letter to the Editor Springer Nature Singapore 2022-06-14 2022-08 /pmc/articles/PMC9197092/ /pubmed/35701541 http://dx.doi.org/10.1038/s41422-022-00681-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Liu, Xiaoqiang Li, Yuhua Wang, Zhongfang Cao, Shouchun Huang, Weijin Yuan, Lin Huang, Yi-Jiao Zheng, Yan Chen, Jingjing Ying, Bo Xiang, Zuoyun Shi, Jin Zhao, Jincun Huang, Zhen Qin, Cheng-Feng Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults |
| title | Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults |
| title_full | Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults |
| title_fullStr | Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults |
| title_full_unstemmed | Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults |
| title_short | Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults |
| title_sort | safety and superior immunogenicity of heterologous boosting with an rbd-based sars-cov-2 mrna vaccine in chinese adults |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197092/ https://www.ncbi.nlm.nih.gov/pubmed/35701541 http://dx.doi.org/10.1038/s41422-022-00681-3 |
| work_keys_str_mv | AT liuxiaoqiang safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT liyuhua safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT wangzhongfang safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT caoshouchun safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT huangweijin safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT yuanlin safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT huangyijiao safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT zhengyan safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT chenjingjing safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT yingbo safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT xiangzuoyun safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT shijin safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT zhaojincun safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT huangzhen safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults AT qinchengfeng safetyandsuperiorimmunogenicityofheterologousboostingwithanrbdbasedsarscov2mrnavaccineinchineseadults |